Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Ginsenosides from Korean Red Ginseng ameliorate lung inflammatory responses: inhibition of the MAPKs/NF-κB/c-Fos pathways

  • Received : 2016.11.24
  • Accepted : 2017.05.17
  • Published : 2018.10.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Korean Red Ginseng (steamed and dried white ginseng, Panax ginseng Meyer) is well known for enhancing vital energy and immune capacity and for inhibiting cancer cell growth. Some clinical studies also demonstrated a therapeutic potential of ginseng extract for treating lung inflammatory disorders. This study was conducted to establish the therapeutic potential of ginseng saponins on the lung inflammatory response. Methods: From Korean Red Ginseng, 11 ginsenosides (Rb1, Rb2, Rb3, Rc, Rd, Re, Rf, Rg1, Rg2, Rg3, and Rh2) were isolated. Their inhibitory potential and action mechanism were evaluated using a mouse model of lung inflammation, acute lung injury induced by intranasal lipopolysaccharide administration. Their anti-inflammatory activities were also examined in lung epithelial cell line (A549) and alveolar macrophage (MH-S). Results: All ginsenosides orally administered at 20 mg/kg showed 11.5-51.6% reduction of total cell numbers in bronchoalveolar lavage fluid (BALF). Among the ginsenosides, Rc, Re, Rg1, and Rh2 exhibited significant inhibitory action by reducing total cell numbers in the BALF by 34.1-51.6% (n = 5). Particularly, Re showed strong and comparable inhibitory potency with that of dexamethasone, as judged by the number of infiltrated cells and histological observations. Re treatment clearly inhibited the activation of mitogen-activated protein kinases, nuclear factor-${\kappa}B$, and the c-Fos component in the lung tissue (n = 3). Conclusion: Certain ginsenosides inhibit lung inflammatory responses by interrupting these signaling molecules and they are potential therapeutics for inflammatory lung diseases.

Keywords

References

  1. Al-Kassimi FA, Alhamad EH. A challenge to the seven widely believed concepts of COPD. Int J Chron Obstruct Pulmon Dis 2013;8:21-30.
  2. Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 2014;35:71-86. https://doi.org/10.1016/j.ccm.2013.10.004
  3. Mulhall AM, Droege CA, Ernst NE, Panos RJ, Zafar MA. Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs. Expert Opin Investig Drugs 2015;30:1-15.
  4. Yonetomi Y, Sekioka T, Kadode M, Kitamine T, Kamiya A, Nakao T, Nomura H, Murata M, Nakao S, Nambu F, et al. Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a Guinea pig model of asthma. Eur J Pharmacol 2015;765:242-8. https://doi.org/10.1016/j.ejphar.2015.08.041
  5. Lee JH, Lim H, Shehzad O,KimYS,Kim HP. Ginsenosides from Korean red ginseng inhibit matrix metalloproteinase-13 expression in articular chondrocytes and prevent cartilage degradation. Eur J Pharmacol 2014;724:145-51. https://doi.org/10.1016/j.ejphar.2013.12.035
  6. Mochizuki M, Yo YungChoon, Matsuzawa K, Saiki I, Tonooka S, Samukawa K, Azuma I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenosides Rb2, 20(R)- and 20(S)-ginsenoside Rg3, of red ginseng. Biol Pharm Bull 1995;18:1197-202. https://doi.org/10.1248/bpb.18.1197
  7. Nag SA, Qin JJ, Wang MH, Wang H, Zhang R. Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationship, and molecular mechanisms of action. Front Pharmacol 2012;3:25.
  8. Wu JY, Gardner BH, Murphy CI, Seals JR, Kensil CR, Recchia J, Beltz GA, Newman GW, Newman MJ. Saponin adjuvant enhancement of antigenspecific immune responses to an experimental HIV-1 vaccine. J Immunol 1992;148:1519-25.
  9. Huh J. Dongeui Bogam (1613). Translated version (translated by Dongeui Research Institute). Seoul: Ryo-gang Publishing; 1994.
  10. Du J, Cheng B, Zhu X, Ling C. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects. J Immunol 2011;187:942-50. https://doi.org/10.4049/jimmunol.1002579
  11. Lee DC, Lau AS. Effects of Panax ginseng on tumor necrosis factor-a-mediated inflammation: a mini-review. Molecules 2011;16:2802-16. https://doi.org/10.3390/molecules16042802
  12. Shergis JL, Di YM, Zhang AL, Vlahos R, Helliwell R, Ye JM, Xue CC. Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease. Complement Ther Med 2014;22:944-53. https://doi.org/10.1016/j.ctim.2014.08.006
  13. Joh EH, Lee IA, Jung IH, Kim DH. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem Pharmacol 2011;82:278-86. https://doi.org/10.1016/j.bcp.2011.05.003
  14. Gaffey K, Reynolds S, Plumb J, Kaur M, Singh D. Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs. Eur Respir J 2013;42:28-41. https://doi.org/10.1183/09031936.00170711
  15. Renda T, Baraldo S, Pelaia G, Bazzan E, Turato G, Papi A, Maestrelli P, Maselli R, Vatrella A, Fabbri LM, et al. Increased activation of p38 MAPK in COPD. Eur Respir J 2008;31:62-9. https://doi.org/10.1183/09031936.00036707
  16. Singh D, Smyth L, Borrill Z, Sweeney L, Tal-Singer R. A randomized, placebocontrolled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients. J Clin Pharmacol 2010;50:94-100. https://doi.org/10.1177/0091270009347873
  17. Babayigit A, Olmez D, Karaman O, Bagriyanik HA, Yilmaz O, Kivcak B, Erbil G, Uzuner N. Ginseng ameliorates chronic histopathologic changes in a murine model of asthma. Allergy Asthma Proc 2008;29:493-8. https://doi.org/10.2500/aap.2008.29.3137
  18. Chen T, Xiao L, Zhu L, Ma S, Yan T, Ji H. Anti-asthmatic effects of ginsenoside Rb1 in a mouse model of allergic asthma through relegating Th1/Th2. Inflammation 2015;38:1814-22. https://doi.org/10.1007/s10753-015-0159-4
  19. Li LC, Piao HM, Zheng MY, Lin ZH, Choi YH, Yan GH. Ginsenoside Rh2 attenuates allergic airway inflammation by modulating nuclear $factor-{\kappa}B$ activation in a murine model of asthma. Mol Med Rep 2015;12:6946-54. https://doi.org/10.3892/mmr.2015.4272
  20. Kim TW, Joh EH, Kim B, Kim DH. Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages. Int Immunopharmacol 2012;12:110-6. https://doi.org/10.1016/j.intimp.2011.10.023
  21. Gross D, Shenkman Z, Bleiberg B, Dayan M, Gittelson M, Efrat R. Ginseng improves pulmonary functions and exercise capacity in patients with COPD. Monaldi Arch Chest Dis 2002;57:242-6.
  22. Scaglione F, Weiser K, Alessandria M. Effects of the standardized ginseng extract G115 (TM) in patients with chronic bronchitis: a nonblinded, randomized, comparative pilot study. Clin Drug Investig 2001;21:41-5. https://doi.org/10.2165/00044011-200121010-00006
  23. Lee CS, Lee JH, Oh M, Choi KM, Jeong MR, Park JD, Kwon DY, Ha KC, Park EO, Lee N, et al. Preventive effect of Korean red ginseng for acute respiratory illness: A randomized and double-blind clinical trial. J Korean Med Sci 2012;27:1472-8. https://doi.org/10.3346/jkms.2012.27.12.1472
  24. Shehzad O, Kim HP, Kim YS. State-of-the-art separation of ginsenosides from Korean white and red ginseng by countercurrent chromatography. Anal Bioanal Chem 2013;405:4523-30. https://doi.org/10.1007/s00216-012-6609-z
  25. Chapman RW, Minnicozzi M, Celly CS, Phillips JE, Kung TT, Hipkim RW, Fan X, Rindgen D, Deno G, Bond R, et al. A novel orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. J Pharmacol Exp Ther 2007;322:486-93. https://doi.org/10.1124/jpet.106.119040
  26. Lim HJ, Jin HG, Woo ER, Lee SK, Kim HP. The root barks of Morus alba and the flavonoid constituents inhibit airway inflammation. J Ethnopharmacol 2013;149:169-75. https://doi.org/10.1016/j.jep.2013.06.017
  27. Blackwell T, Yull FE, Chen CL, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 2000;162:1095-101. https://doi.org/10.1164/ajrccm.162.3.9906129
  28. Lee JH, Lim HJ, Lee CW, Son KH, Son JK, Lee SK, Kim HP. Methyl protodioscin from the roots of Asparagus cochinchinensis attenuates airway inflammation by inhibiting cytokine production. Evid Based Complement Alternat Med 2015;2015:640846.
  29. Ko HJ, Jin JH, Kwon OS, Kim JT, Son KH, Kim HP. Inhibition of experimental lung inflammation and bronchitis by phytoformula containing Broussonetia papyrifera and Lonicera japonica. Biomol Ther (Seoul) 2011;19:324-30. https://doi.org/10.4062/biomolther.2011.19.3.324
  30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 1983;65:55-63. https://doi.org/10.1016/0022-1759(83)90303-4
  31. Park EK, Shin YW, Lee HU, Kim SS, Lee YC, Lee BY, Kim DH. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol Pharm Bull 2005;28:652-6. https://doi.org/10.1248/bpb.28.652
  32. Millan DS, Bunnage ME, Burrows JL, Butcher KJ, Dodd PG, Evans TJ, Fairman DA, Hughes SJ, Kilty IC, Lemaitre A, et al. Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease. J Med Chem 2011;54:7797-814. https://doi.org/10.1021/jm200677b

Cited by

  1. Red Ginseng Reduces Inflammatory Response via Suppression MAPK/P38 Signaling and p65 Nuclear Proteins Translocation in Rats and Raw 264.7 Macrophage vol.47, pp.7, 2018, https://doi.org/10.1142/s0192415x19500812
  2. Ginsenoside Rb1, A Major Saponin from Panax ginseng , Exerts Protective Effects Against Acetaminophen-Induced Hepatotoxicity in Mice vol.47, pp.8, 2018, https://doi.org/10.1142/s0192415x19500927
  3. The Effects of Korea Red Ginseng on Inflammatory Cytokines and Apoptosis in Rat Model with Chronic Nonbacterial Prostatitis vol.2019, pp.None, 2018, https://doi.org/10.1155/2019/2462561
  4. Modulation of Autophagy for Controlling Immunity vol.8, pp.2, 2018, https://doi.org/10.3390/cells8020138
  5. Ginsenoside Rg3 suppresses mast cell-mediated allergic inflammation via mitogen-activated protein kinase signaling pathway vol.43, pp.2, 2018, https://doi.org/10.1016/j.jgr.2018.02.008
  6. Phenolic Compounds and Ginsenosides in Ginseng Shoots and Their Antioxidant and Anti-Inflammatory Capacities in LPS-Induced RAW264.7 Mouse Macrophages vol.20, pp.12, 2018, https://doi.org/10.3390/ijms20122951
  7. Red Ginseng Attenuates Aβ-Induced Mitochondrial Dysfunction and Aβ-mediated Pathology in an Animal Model of Alzheimer’s Disease vol.20, pp.12, 2019, https://doi.org/10.3390/ijms20123030
  8. Ginseng: A Qualitative Review of Benefits for Palliative Clinicians vol.36, pp.7, 2018, https://doi.org/10.1177/1049909118822704
  9. KGC3P attenuates ovalbumin-induced airway inflammation through downregulation of p-PTEN in asthmatic mice vol.62, pp.None, 2019, https://doi.org/10.1016/j.phymed.2019.152942
  10. Electro-Acupuncture Alleviates Cisplatin-Induced Anorexia in Rats by Modulating Ghrelin and Monoamine Neurotransmitters vol.9, pp.10, 2018, https://doi.org/10.3390/biom9100624
  11. Archidendron lucidum Exerts Anti-Inflammatory Effects by Targeting PDK1 in the NF- $ \kappa $ B Pathway vol.48, pp.2, 2018, https://doi.org/10.1142/s0192415x20500226
  12. Potential Moracin M Prodrugs Strongly Attenuate Airway Inflammation In Vivo vol.28, pp.4, 2018, https://doi.org/10.4062/biomolther.2019.212
  13. Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/1636816
  14. Elucidation of the Mechanism of Action of Ginseng Against Acute Lung Injury/Acute Respiratory Distress Syndrome by a Network Pharmacology-Based Strategy vol.11, pp.None, 2018, https://doi.org/10.3389/fphar.2020.611794
  15. Effect of Korean Red Ginseng and Rg3 on Asian Sand Dust-Induced MUC5AC, MUC5B, and MUC8 Expression in Bronchial Epithelial Cells vol.26, pp.7, 2018, https://doi.org/10.3390/molecules26072002
  16. CD38 deficiency up-regulated IL-1β and MCP-1 through TLR4/ERK/NF-κB pathway in sepsis pulmonary injury vol.23, pp.9, 2018, https://doi.org/10.1016/j.micinf.2021.104845
  17. Administration of red ginseng regulates microRNA expression in a mouse model of endometriosis vol.48, pp.4, 2018, https://doi.org/10.5653/cerm.2021.04392